Please login to the form below

Not currently logged in
Email:
Password:

Merck & Co expands board and adds new directors

Appoints Dr Paul Rothman and Pamela Craig

Merck & Co has appointed Dr Paul Rothman and Pamela Craig to two newly-created spaces on its board, with effect from next month, bringing its total members to 14.

Dr Rothman, who will serve as a member of Merck's research committee, is dean of the medical faculty and vice president for medicine at The Johns Hopkins University and chief executive officer of Johns Hopkins Medicine.

A rheumatologist and molecular immunologist, he joined Johns Hopkins in July 2012 after having served as dean of the Carver College of Medicine at the University of Iowa and leader of its clinical practice plan since 2008.

Meanwhile, Craig is a former chief financial officer of Accenture and will serve as a member of Merck's audit committee.

Craig, who retired from Accenture in 2013, spent 34 years at the consulting firm and is currently a senior advisor for advisory firm Teneo, is a member of the board for the tech firms Akamai Technologies and VMware and for Wal-Mart Stores.

Kenneth Frazier, Merck's chairman and chief executive officer, said: “We are pleased to welcome Pamela Craig and Dr Paul Rothman to the Merck board. Each brings a tremendous wealth of experience and expertise in their respective fields.

“We are confident that their contributions and insights will further strengthen the board.”

31st July 2015

From: Research, Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

11 London is a strategic and creative agency working in the fields of health and humanity – complex areas, but...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics